期刊文献+

原发性干燥综合征合并自身免疫性甲状腺病 被引量:3

Autoimmune thyroid disease in primary Sjgren syndrome
原文传递
导出
摘要 目的了解合并自身免疫性甲状腺病的原发性干燥综合征(pSS)临床特点。方法检测41例住院治疗的pSS患者甲状腺功能、甲状腺抗体,比较pSS中甲状腺功能正常者与合并自身免疫性甲状腺病者临床特征。结果41例pSS患者中女性39例(95.1%),平均发病年龄42.6岁;甲状腺功能异常18例(43.9%),其中13例甲状腺功能减低,5例甲状腺功能亢进;7例诊断为自身免疫性甲状腺病(桥本甲状腺炎4例,Graves病3例)。与甲状腺功能正常的患者相比,合并自身免疫性甲状腺病的pSS患者甲状腺肿大发生率增高(P<0.01),同时血红蛋白降低而球蛋白或IgG增高(P<0.05)。结论PSS合并自身免疫性甲状腺病并不少见,对于存在高球蛋白血症和贫血的患者应常规进行甲状腺功能和抗体检测。 Objective To study the clinical features of primary Sjoegren syndrome (pSS) in patients with autoimmune thyroid disease. Methods Thyroid function and thyroid antibodies of 41 pSS cases were measured. Clinical manifestations and laboratory results of those with normal thyroid function and those with autoimmune thyroid disease were analyzed. Results Among 41 pSS patients, 95.1% was female with average onset age of 42.6 years old. Eighteen patients (43.9%) had abnormal thyroid function, of which 13 cases were hypothyroidism and 5 were hyperthyroidism. Seven cases were diagnosed with autoimmune thyroid disease, including four with Hashimoto thyroiditis and three with Graves's disease. As compared to the pSS patients with normal thyroid function, enlarged thyroid, decreased hemoglobin and elevated globulin or IgG were found to be more prominent in those accompanied with autoimmune thyroid disease (P〈 0. 05 ). Conclusion Autoimmune thyroid disease is common in pSS. Those with anemia and hyperglobulinemia should be routinely tested for thyroid function and its antibodies.
出处 《江苏医药》 CAS CSCD 北大核心 2009年第1期72-74,共3页 Jiangsu Medical Journal
关键词 原发性干燥综合征 自身免疫性甲状腺病 Primary Sjoegren syndrome Autoimmune thyroid disease
  • 相关文献

参考文献7

  • 1Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002, 61(6): 554-558.
  • 2徐立勤,胡春燕.原发性干燥综合征合并甲状腺功能异常的临床研究[J].浙江预防医学,2005,17(8):62-62. 被引量:2
  • 3黄菁梅,张学武,贾园,穆荣,栗占国.原发性干燥综合征合并甲状腺功能异常的临床及血清学分析[J].中华风湿病学杂志,2002,6(6):456-458. 被引量:9
  • 4Jara LJ, Navarro C. Thyroid disease in Sjogren's syndrome[J].Clin Rheumatol,2007, 26(10) : 1601-1606.
  • 5Gomez LM, Anaya JM, Gonzalez CI, et al. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases [J]. Genes Immun,2005, 6(7):628-631.
  • 6Wu H, Cantor RM, Graham DS,et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease[J]. Arthritis Rheum, 2005, 52(8) : 2396-2402.
  • 7袁双龙,蒋莉,张晓莉,李舒帆,段宏梅,王晓非.原发性干燥综合症患者血清IL-21水平及其临床意义[J].细胞与分子免疫学杂志,2007,23(2):124-126. 被引量:19

二级参考文献20

  • 1杨敏,张泽松,李守静,刘复强,赵相印,刘士廉,郑德先.自身免疫病患者T淋巴细胞表型分析[J].免疫学杂志,1995,11(2):124-126. 被引量:2
  • 2Vitali C, Bombardieri S, Jonsson R, et al, Classication criteria for Sjogren' s syndrome [J]. Ann Rheum Dis, 2002, 61: 554~558.
  • 3D' Arbonneau F, Ansart S, Le Berre R, et al, Thyroid dysfunction in primary Sjogren' s syndrome: a long-term followup study [J].Arthritis Rheum, 2003, 15, 49 (6): 804 ~ 809.
  • 4Coll J, Tomas S, Anglada J, etal. Prevalence of Sjogren' ssyndrome in autoimmune thyroid disease [J]. Brest, 1994, J Rheumatol,1997, Sep, 24 (9): 1719~ 1724.
  • 5Ozgen AG, Keser G, Erdem N, et al, Hypothalamus-hypophysisthyroid axis, triiodothyronine and antithyroid antibodies in patients with primary and secondary Sjogren' s syndrome [ J ]. Clin Rheumatol,2001, 20 (1): 44~48.
  • 6Fox RI,Saito I.Criteria for diagnosis of Sjogren′s syndrome.Med Clin North Am,1994,20:391.
  • 7Perez B,Kraus A,Lopez G,et al.Autoimmune thyroid disease in primary Sjogren′s syndrome.Am J Med,1985,99:480-484.
  • 8Ramos-Casals M,Garcia-Carrasco Mcrvera R,Gaya J,et al.Thyroid disease in primary Sjogren′s syndrome:study in a series of 160 patients.Medicine(Baltimore),2000,79:103-108.
  • 9Karsh J,Pavlidis N,Weintraub BD,et al.Thyroid disease in Sjogren′s syndrome.Arthritis Rheum,1980,23:1326-1329.
  • 10Parrish-Novak J,Dillon SR,Nelson A,et al.Interleukine-21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function[J].Nature,2000,408(6808):57-63.

共引文献27

同被引文献32

  • 1费允云,吴迪,张奉春.原发性干燥综合征的中枢神经系统病变[J].中华全科医师杂志,2006,5(2):102-104. 被引量:8
  • 2陆再英,钟南山.内科学[M].7版.人民卫生出版社,2008:263-272.
  • 3Vitali C,Bombardieri S,Jonsson R,et al.Classification criteria for Sjǒgren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group.Ann Rheum Dis,2002,61:554-558.
  • 4Fazekas F,Klcinert R,Offenbacher H,et al.Pathologic correlates of incidental MRI white matter signal hyperintensities.Neurology,1993,43:1683-1689.
  • 5Shusta EV,Li JY,Boado RJ,et al.The RO52/SS-A autoantigen has elevated expression at the brain microvasculature.Neuroreport,2003,14:1861-1865.
  • 6Delalande S,de Seze J,Fauchais AL,et al.Neurologic manifestations in primary Sjgren's syndrome:a study of 82 patients.Medicine,2004,83:280-291.
  • 7Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines [ J]. Immunity, 2005, 23(5) : 479 -490.
  • 8Chackerian AA, Oldham ER, Murphy EE, et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex [ J ]. J Immunol, 2007, 179(4) : 2551 -2555.
  • 9Ali S, Huber M, Kollewe C, et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells [J]. Proc Nat Acad Sc U S A, 2007, 104(47) : 18660 -18665.
  • 10Komai-Koma M, Xu D, Li Y, et al. IL-33 is a chemoattractant for human Th2 cells [ J]. Eur J Immunol, 2007, 37 (10) : 2779 - 2786.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部